C4ORF29 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.165600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.230200E-01
Normal-vs-Stage2
9.136000E-01
Normal-vs-Stage3
2.782000E-01
Normal-vs-Stage4
3.323200E-01
Stage1-vs-Stage2
5.787000E-01
Stage1-vs-Stage3
1.866600E-01
Stage1-vs-Stage4
5.325000E-01
Stage2-vs-Stage3
1.719840E-01
Stage2-vs-Stage4
2.169600E-01
Stage3-vs-Stage4
3.393800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.511800E-01
Normal-vs-AfricanAmerican
8.883200E-01
Normal-vs-Asian
5.044800E-01
Caucasian-vs-AfricanAmerican
7.485400E-01
Caucasian-vs-Asian
2.489200E-01
AfricanAmerican-vs-Asian
3.171400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.064000E-01
Normal-vs-Female
9.395000E-01
Male-vs-Female
8.532600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.692600E-01
Normal-vs-Age(41-60Yrs)
8.230600E-01
Normal-vs-Age(61-80Yrs)
8.323200E-01
Normal-vs-Age(81-100Yrs)
6.185400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.067000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.111200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.140000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.221220E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.544410E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.942600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.680200E-01
Normal-vs-Daily Drinker
3.986800E-01
Normal-vs-Weekly Drinker
8.687400E-01
Normal-vs-Occasional Drinker
9.359600E-01
Normal-vs-Social Drinker
8.086200E-01
Non Drinker-vs-Daily Drinker
1.267630E-01
Non Drinker-vs-Weekly Drinker
8.994200E-01
Non Drinker-vs-Occasional Drinker
8.536400E-01
Non Drinker-vs-Social Drinker
4.118600E-01
Daily Drinker-vs-Weekly Drinker
3.754800E-01
Daily Drinker-vs-Occasional Drinker
1.202790E-01
Daily Drinker-vs-Social Drinker
5.524500E-02
Weekly Drinker-vs-Occasional Drinker
8.134400E-01
Weekly Drinker-vs-Social Drinker
5.132000E-01
Occasional Drinker-vs-Social Drinker
5.413600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.690300E-02
Normal-vs-Grade 2
3.815200E-03
Normal-vs-Grade 3
2.901600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.568000E-01
Grade 1-vs-Grade 3
5.653200E-01
Grade 1-vs-Grade 4
7.690300E-02
Grade 2-vs-Grade 3
3.423600E-01
Grade 2-vs-Grade 4
3.815200E-03
Grade 3-vs-Grade 4
2.901600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.253200E-01
Normal-vs-NonDiabetic
8.448200E-01
Diabetic-vs-NonDiabetic
6.339000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.707800E-01
Normal-vs-NoPancreatitis
7.817200E-01
Pancreatitis-vs-NoPancreatitis
2.702200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.493400E-01
Normal-vs-N1
8.728600E-01
N0-vs-N1
5.116400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.602200E-01
Normal-vs-TP53-NonMutant
6.670800E-01
TP53-Mutant-vs-TP53-NonMutant
3.544000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
